ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Routine Sterile Gloving in Blood Culture

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00973063
Recruitment Status : Completed
First Posted : September 9, 2009
Last Update Posted : December 4, 2013
Sponsor:
Information provided by (Responsible Party):
Wan Beom Park, Seoul National University Hospital

Study Description
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to determine whether routine sterile gloving can lower contamination rates in blood culture.

Condition or disease Intervention/treatment Phase
Bacteremia Behavioral: Routine sterile gloving Not Applicable

Detailed Description:
Because contamination during sampling for blood culture may interfere in interpreting the results of blood culture, lowering the contamination rates in blood culture is very important. According to current guideline, routine sterile gloving is not recommended. We hypothesized that routine sterile gloving can lower contamination rates in blood culture.

Study Design
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 1854 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Diagnostic
Official Title: Influence of Routine Sterile Gloving on Contamination Rates in Blood Culture
Study Start Date : March 2009
Actual Primary Completion Date : December 2009
Actual Study Completion Date : December 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Infertility
U.S. FDA Resources

Arms and Interventions
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
No Intervention: conventional gloving
Experimental: routine sterile gloving Behavioral: Routine sterile gloving
routinely new sterile gloving just before sampling


Outcome Measures
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. contamination rate in blood culture [ Time Frame: at the time of identification of organisms ]

Eligibility Criteria
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The patients in whom Blood culture is medically needed

Exclusion Criteria:

  • Blood sample is obtained through central venous catheter or arterial line
  • No consent to this study
Contacts and Locations
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00973063


Locations
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Principal Investigator: WAN BEOM PARK, MD Seoul National University Hospital
More Information
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Wan Beom Park, Associate Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT00973063     History of Changes
Other Study ID Numbers: 0906-029-283
SNUHIMI01
First Posted: September 9, 2009    Key Record Dates
Last Update Posted: December 4, 2013
Last Verified: December 2013

Keywords provided by Wan Beom Park, Seoul National University Hospital:
bacteremia
blood culture
contamination

Additional relevant MeSH terms:
Bacteremia
Bacterial Infections
Sepsis
Infection
 Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes